SCHEMBL23188271

SCHEMBL23188271

CCc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)c2ccc(OC)cc2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADCY1 Q08828 20/20 1.00
ADCY8 P40145 17/20 0.82
HTR2B P41595 3/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23188264 0.92 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL23188253 0.91 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL23188272 0.90 ADCY1 (0.86) ADCY1ADCY8HTR2B
SCHEMBL23188326 0.90 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL23188249 0.90 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL23188322 0.89 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL20672996 0.89 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL20673090 0.89 ADCY1 (1.00) ADCY1ADCY8HTR2B
SCHEMBL25798512 0.88 ADCY1 (0.89) ADCY1ADCY8HTR2B
SCHEMBL25798884 0.87 ADCY1 (0.82) ADCY1ADCY8HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293523-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2023-09-21 US disclosed
US-20230250084-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2023-08-10 US disclosed
US-11690844-B2 Pyrazolyl pyrimidinone compounds and the uses thereof PURDUE RESEARCH FOUNDATION (US) 2023-07-04 US disclosed
US-20210100797-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2021-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690844-B2 Pyrazolyl pyrimidinone compounds and the uses thereof CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20230250084-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20230293523-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20210100797-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.